Počet záznamov: 1
dipyridamol
SYS d004176 LBL 00000nz--a2200000o--4500 005 20250606214310.5 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D03.383.742.175 066 $a 01 $c 03 150 $a dipyridamol $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d010726 $Y Phosphodiesterase Inhibitors $w P $a inhibítory fosfodiesteráz 550 $7 sllk_us_auth*d010975 $Y Platelet Aggregation Inhibitors $w P $a inhibítory agregácie trombocytov 550 $7 sllk_us_auth*d014665 $Y Vasodilator Agents $w P $a látky vazodilatačné 665 $a 66; was PERSANTIN 1963-65 $2 eng 680 9-
$i A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) $2 eng 750 -2
$a Dipyridamole $2 eng 980 $x M
Počet záznamov: 1